Nanomedicine News

RSS

Targeted Nanoparticle May Help Regenerate Healthy Heart Tissue without Using Stem Cells

A targeted nanoparticle created by researchers at North Carolina State University and the Cedars-Sinai Heart Institute may help heart attack patients regenerate healthy heart tissue without using donated or processed stem cells. This new nanomedicine could also alleviate some of the difficulties involved with stem cell therapy, including treatment delays and invasive procedures.

From North Carolina State University 12 Sep 2014

Nanorobotic Techniques and AFM Help Study Pathology of Autoimmune Skin Disease

University at Buffalo researchers and colleagues studying a rare, blistering disease have discovered new details of how autoantibodies destroy healthy cells in skin. This information provides new insights into autoimmune mechanisms in general and could help develop and screen treatments for patients suffering from all autoimmune diseases, estimated to affect 5-10 percent of the U.S. population.

11 Sep 2014

Antibody-Studded Iron Nanoparticles Help Treat Heart Attack Damage

Researchers at the Cedars-Sinai Heart Institute infused antibody-studded iron nanoparticles into the bloodstream to treat heart attack damage. The combined nanoparticle enabled precise localization of the body's own stem cells to the injured heart muscle.

11 Sep 2014

Senesco Technologies Changes Name to Sevion Therapeutics

Senesco Technologies, Inc., a clinical-stage company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, announced today a corporate rebranding under which the Company will change its name to Sevion Therapeutics, Inc.

10 Sep 2014

NanoViricides Reports Further Progress in Development of Anti-Ebola Drug Program

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reported further progress in its anti-Ebola drug development program. The Company has designed novel anti-Ebola broad-spectrum drug candidates that are expected to continue to work in spite of mutations, and has commenced synthesis of the same.

From NanoViricides, Inc 10 Sep 2014

Inventor of Miniaturized Technologies to Improve Human Health Wins $500,000 Lemelson-MIT Prize

Dr. Sangeeta Bhatia, biomedical engineer and professor at MIT, is the recipient of the 2014 $500,000 Lemelson-MIT Prize. Bhatia is recognized for designing and commercializing miniaturized technologies with applications to improve human health.

10 Sep 2014

Pre-Clinical Data on Pregnant Baboons Immunized with Novavax RSV F Nanoparticle Vaccine Presented at 54th ICAAC

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced pre-clinical data presented on Sunday, September 7, 2014, at 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC.

From Novavax Inc. 9 Sep 2014

PharmAthene, Nanotherapeutics Enter Alliance to Advance Medical Countermeasures for Biodefense

PharmAthene, Inc. and Nanotherapeutics, Inc., a privately-held biopharmaceutical company, announced today that they have formed a Strategic Alliance to advance the development of certain medical countermeasures for the U.S. biodefense market.

9 Sep 2014

SUNY CNSE/SUNYIT Awarded Grant to Identify Cancer Cell Signals using Nanotechnology-Enabled Methods

The newly merged SUNY College of Nanoscale Science and Engineering (CNSE)/SUNY Institute of Technology (SUNYIT) institution today announced the National Institute of Environmental Health Sciences has awarded a $1.65 million grant to further research conducted by nanobioscience professor Dr. Thomas Begley that identifies signals which cancer cells use to respond to their environment.

9 Sep 2014

Diagnostic Tool for Therapeutic Plasma Medicine

The potential for deployment of cold plasma sources in medical and biological applications continues to increase in areas such as dentistry, surgery, wound sterilisation and general surface decontamination. Successful optimisation of these gas-phase cold plasmas requires detailed characterisation and quantification of the plasma beam to establish the actual abundances of the reactive species within the feed-gas and the variances with feed-gas composition.

From Hiden Analytical 8 Sep 2014

Nanomedicine News

Targeted Nanoparticle May Help Regenerate Healthy Heart Tissue without Using Stem Cells

Nanorobotic Techniques and AFM Help Study Pathology of Autoimmune Skin Disease

Antibody-Studded Iron Nanoparticles Help Treat Heart Attack Damage

Senesco Technologies Changes Name to Sevion Therapeutics

NanoViricides Reports Further Progress in Development of Anti-Ebola Drug Program

Inventor of Miniaturized Technologies to Improve Human Health Wins $500,000 Lemelson-MIT Prize

Pre-Clinical Data on Pregnant Baboons Immunized with Novavax RSV F Nanoparticle Vaccine Presented at 54th ICAAC

PharmAthene, Nanotherapeutics Enter Alliance to Advance Medical Countermeasures for Biodefense

SUNY CNSE/SUNYIT Awarded Grant to Identify Cancer Cell Signals using Nanotechnology-Enabled Methods

Diagnostic Tool for Therapeutic Plasma Medicine

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials